These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 26976625)
1. Introduction and overview of the special issue "Brain imaging and aging": The new era of neuroimaging in aging research. Furukawa K; Ishiki A; Tomita N; Onaka Y; Saito H; Nakamichi T; Hara K; Kusano Y; Ebara M; Arata Y; Sakota M; Miyazawa I; Totsune T; Okinaga S; Okamura N; Kudo Y; Arai H Ageing Res Rev; 2016 Sep; 30():1-3. PubMed ID: 26976625 [TBL] [Abstract][Full Text] [Related]
2. Molecular imaging of dementia. Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644 [TBL] [Abstract][Full Text] [Related]
3. Structural and functional imaging correlates for age-related changes in the brain. Tumeh PC; Alavi A; Houseni M; Greenfield A; Chryssikos T; Newberg A; Torigian DA; Moonis G Semin Nucl Med; 2007 Mar; 37(2):69-87. PubMed ID: 17289456 [TBL] [Abstract][Full Text] [Related]
4. Functional imaging of the brain in the evaluation of drug response and its application to the study of aging. Bryant CA; Jackson SH Drugs Aging; 1998 Sep; 13(3):211-22. PubMed ID: 9789725 [TBL] [Abstract][Full Text] [Related]
6. MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden. Banerjee G; Kim HJ; Fox Z; Jäger HR; Wilson D; Charidimou A; Na HK; Na DL; Seo SW; Werring DJ Brain; 2017 Apr; 140(4):1107-1116. PubMed ID: 28335021 [TBL] [Abstract][Full Text] [Related]
7. [Neuroimaging in Alzheimer's disease: a synthesis and a contribution to the understanding of physiopathological mechanisms]. Villain N; Chételat G; Desgranges B; Eustache F Biol Aujourdhui; 2010; 204(2):145-58. PubMed ID: 20950559 [TBL] [Abstract][Full Text] [Related]
8. APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease. Reinvang I; Espeseth T; Westlye LT Neurosci Biobehav Rev; 2013 Sep; 37(8):1322-35. PubMed ID: 23701948 [TBL] [Abstract][Full Text] [Related]
9. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia. Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A; Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175 [TBL] [Abstract][Full Text] [Related]
10. Different patterns of brain activation in normal aging and Alzheimer's disease from cognitional sight: meta analysis using activation likelihood estimation. Sadigh-Eteghad S; Majdi A; Farhoudi M; Talebi M; Mahmoudi J J Neurol Sci; 2014 Aug; 343(1-2):159-66. PubMed ID: 24950901 [TBL] [Abstract][Full Text] [Related]
11. Contribution of neuroimaging to the diagnosis of Alzheimer's disease and vascular dementia. Román G; Pascual B Arch Med Res; 2012 Nov; 43(8):671-6. PubMed ID: 23142262 [TBL] [Abstract][Full Text] [Related]
12. Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease. Schöll M; Ossenkoppele R; Strandberg O; Palmqvist S; ; Jögi J; Ohlsson T; Smith R; Hansson O Brain; 2017 Sep; 140(9):2286-2294. PubMed ID: 29050382 [TBL] [Abstract][Full Text] [Related]
13. [Brain imaging of Alzheimer' disease: state of the art and perspectives for clinicians]. Trombella S; Assal F; Zekry D; Gold G; Giannakopoulos P; Garibotto V; Démonet JF; Frisoni GB Rev Med Suisse; 2016 Apr; 12(515):795-8. PubMed ID: 27276723 [TBL] [Abstract][Full Text] [Related]
14. Linking brain imaging and genomics in the study of Alzheimer's disease and aging. Reiman EM Ann N Y Acad Sci; 2007 Feb; 1097():94-113. PubMed ID: 17413015 [TBL] [Abstract][Full Text] [Related]
16. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography. Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834 [TBL] [Abstract][Full Text] [Related]
17. Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults. Dumurgier J; Hanseeuw BJ; Hatling FB; Judge KA; Schultz AP; Chhatwal JP; Blacker D; Sperling RA; Johnson KA; Hyman BT; Gómez-Isla T J Alzheimers Dis; 2017; 60(4):1451-1459. PubMed ID: 29036824 [TBL] [Abstract][Full Text] [Related]
18. NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers. Vos SJB; Gordon BA; Su Y; Visser PJ; Holtzman DM; Morris JC; Fagan AM; Benzinger TLS Neurobiol Aging; 2016 Aug; 44():1-8. PubMed ID: 27318129 [TBL] [Abstract][Full Text] [Related]
19. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies. Thal DR; Attems J; Ewers M J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313 [TBL] [Abstract][Full Text] [Related]
20. Neuroimaging and genetics in aging and age-related disease. Van Horn JD Brain Imaging Behav; 2014 Jun; 8(2):141-2. PubMed ID: 24623094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]